- Home
- AKRO vs BTSG Comparison
AKRO vs BTSG Comparison
Compare AKRO & BTSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- BTSG
- Stock Information
- Founded
- AKRO 2017
- BTSG 1974
- Country
- AKRO United States
- BTSG United States
- Employees
- AKRO N/A
- BTSG N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- BTSG
- Sector
- AKRO Health Care
- BTSG
- Exchange
- AKRO Nasdaq
- BTSG NYSE
- Market Cap
- AKRO 3.9B
- BTSG 4.1B
- IPO Year
- AKRO 2019
- BTSG 2024
- Fundamental
- Price
- AKRO $51.69
- BTSG $20.31
- Analyst Decision
- AKRO Strong Buy
- BTSG Strong Buy
- Analyst Count
- AKRO 6
- BTSG 9
- Target Price
- AKRO $82.50
- BTSG $23.50
- AVG Volume (30 Days)
- AKRO 1.6M
- BTSG 2.9M
- Earning Date
- AKRO 08-08-2025
- BTSG 08-01-2025
- Dividend Yield
- AKRO N/A
- BTSG N/A
- EPS Growth
- AKRO N/A
- BTSG N/A
- EPS
- AKRO N/A
- BTSG 0.29
- Revenue
- AKRO N/A
- BTSG $11,858,835,000.00
- Revenue This Year
- AKRO N/A
- BTSG $11.55
- Revenue Next Year
- AKRO N/A
- BTSG $12.14
- P/E Ratio
- AKRO N/A
- BTSG $71.59
- Revenue Growth
- AKRO N/A
- BTSG 30.55
- 52 Week Low
- AKRO $21.34
- BTSG $10.15
- 52 Week High
- AKRO $58.40
- BTSG $25.57
- Technical
- Relative Strength Index (RSI)
- AKRO 45.35
- BTSG 33.01
- Support Level
- AKRO $50.13
- BTSG $21.36
- Resistance Level
- AKRO $53.60
- BTSG $22.40
- Average True Range (ATR)
- AKRO 2.03
- BTSG 0.71
- MACD
- AKRO -0.83
- BTSG -0.27
- Stochastic Oscillator
- AKRO 6.37
- BTSG 1.84
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About BTSG BRIGHTSPRING HEALTH SERVICES INC
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services and others. It generates the majority of its revenue from the Pharmacy Solutions segment.